Table 2.
Differential diagnosis of vitiligo (1,57) .
| Inherited or genetically induced hypomelanoses(usually present at birth) |
|
|
| Piebaldism |
|
|
| Tuberous sclerosis |
|
|
| Ito's hypomelanosis |
|
|
| Waardenburg's syndrome |
|
|
| Hermanski-Pudlak syndrome |
|
|
| Menkés syndrome |
|
|
| Ziprkowski-Margolis syndrome |
|
|
| Griscelli's syndrome |
|
|
| Post-inflammatory hypomelanoses |
|
|
| Related to an increased epidermal turn over |
|
|
| Psoriasis |
|
|
| Atopic dermatitis |
|
|
| Related to an acute lichenoid/cytotoxic infiltrate with pigment incontinence |
|
|
| Lichen planus |
|
|
| Toxic drug reaction |
|
|
| Para-malignant hypomelanoses |
|
|
| Mycosis fungoides |
|
|
| Melanoma-associated depigmentation |
|
|
| Para-infectious hypopigmentation |
|
|
| Pityriasis versicolor |
|
|
| Leprosy |
|
|
| Leishmaniasis |
|
|
| Onchocerciasis |
|
|
| Acquired macular hypomelanosis |
|
|
| Post traumatic leucoderma |
|
|
| Post-burns |
|
|
| Post-scars |
|
|
| Melasma |
|
|
| Occupational and drug induced depigmentation |
|
|
| Phenolic-catecholic derivatives |
|
|
| Systemic drugs(chloroquine, fluphenazine, physostigmine, imatinib) |
|
|
| Topical drugs (imiquimod, long-term use of topical steroid) |
|
|